Patents by Inventor Nora E. Sarvetnick

Nora E. Sarvetnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR TYPE 1 DIABETES
    Publication number: 20220057398
    Abstract: In various embodiments methods are provided for evaluating the likelihood of a subject progressing to type 1 diabetes. In certain embodiments the methods involve determining the level of CD57+, CD28?, CD127?, CD27?, CD8+ T cells (SLEC CD8 T cells) and the other populations shown in FIG. 10 and/or CCR7dim, CD45RA+, CD8+ T cells derived from a subject where an elevated level of the first populations above, and/or a reduced level of the CCR7dim, CD45RA+, CD8+ T cells as compared to the level(s) in a normal healthy control is an indicator that subject has a significant elevated risk for progression to type I diabetes.
    Type: Application
    Filed: September 11, 2019
    Publication date: February 24, 2022
    Applicant: Board of Regents of the University of Nebraska
    Inventors: Nora E. Sarvetnick, Robert Z. Harms